Numeracy of multiple sclerosis patients: A comparison of patients from the PERCEPT study to a German probabilistic sample

Patient Educ Couns. 2018 Jan;101(1):74-78. doi: 10.1016/j.pec.2017.07.018. Epub 2017 Jul 17.

Abstract

Objective: A shared decision-making approach is suggested for multiple sclerosis (MS) patients. To properly evaluate benefits and risks of different treatment options accordingly, MS patients require sufficient numeracy - the ability to understand quantitative information. It is unknown whether MS affects numeracy. Therefore, we investigated whether patients' numeracy was impaired compared to a probabilistic national sample.

Methods: As part of the larger prospective, observational, multicenter study PERCEPT, we assessed numeracy for a clinical study sample of German MS patients (N=725) with a standard test and compared them to a German probabilistic sample (N=1001), controlling for age, sex, and education. Within patients, we assessed whether disease variables (disease duration, disability, annual relapse rate, cognitive impairment) predicted numeracy beyond these demographics.

Results: MS patients showed a comparable level of numeracy as the probabilistic national sample (68.9% vs. 68.5% correct answers, P=0.831). In both samples, numeracy was higher for men and the highly educated. Disease variables did not predict numeracy beyond demographics within patients, and predictability was generally low.

Conclusion: This sample of MS patients understood quantitative information on the same level as the general population.

Practice implications: There is no reason to withhold quantitative information from MS patients.

Keywords: Cognition; Multiple sclerosis; Numeracy; Shared decision-making.

Publication types

  • Observational Study

MeSH terms

  • Adult
  • Case-Control Studies
  • Cognition*
  • Comprehension*
  • Decision Making*
  • Female
  • Health Literacy*
  • Humans
  • Male
  • Mathematical Concepts*
  • Middle Aged
  • Multiple Sclerosis / psychology
  • Multiple Sclerosis / therapy*
  • Prospective Studies